Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region

Abstract
The global hand, foot, and mouth disease treatment market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of viral infections, and extensive research and development are propelling the growth of the market, globally. Hand, foot, and mouth disease also abbreviated as HFMD is a contagious disease which is caused by enterovirus genus majorly Coxsackievirus A16 and enterovirus A71. These viruses are majorly detected in children below age 10 and is usually spread through skin-to-skin contact, airborne respiratory droplets or by saliva. The other factors supporting the market’s growth are, the increasing government investments on R&D activities, growing footprint of pharmaceutical manufacturers, developed healthcare infrastructure, rising awareness among the masses, and technological advancements. Also, ease in FDA approvals for hand, foot, and mouth disease (HFMD) drugs in clinical trial phase is further projected to drive the growth of hand, foot, and mouth disease treatment market.
High Prevalence of Viral Infection
Viral infections are very common in children below age 10 as they have very low immunity, and they often tend to put their hands in mouth. Hand, foot, and mouth disease (HFMD) is caused by a virus from the Enterovirus genus, most commonly the coxsackievirus. These viruses are transmitted from infected person to other. Owing to the large patient pool due to HFMD, the demand for hand, foot and mouth disease treatment is upsurging. Moreover, growth of the health care industry due to the growing incidences of viruses across the globe is facilitating the market growth. For instance, from 2013−2019, 15,316,710 probable cases of HFMD were reported. Out of these, 787,197 (5·1%) were laboratory confirmed and 76,982 (0·5%) were severe.
Growing Awareness and Research
Over the past few years, increase in awareness among masses about the hand, foot and mouth diseases is seen. Various awareness programs are initiated by governments of different nations, which are propelling the growth of the market. Hand, foot, and mouth disease is widespread pediatric disease which occurs in children under the age of 5. Owing to the rise in number of patients suffering from HFMD, demand for the drug discovery research is rising. This, in turn, propels the market growth. For instance, according to Iranian Journal of Public Health, a study conducted from 2008 to 2015 revealed the incidence of HFMD grew rapidly from 86.59/100,000 in 2009 to 203.16/100,000 in 2014. Moreover, heavy investments by governments and market players on R&D activities and clinical trials, are bolstering the market growth.

Market Segmentation
The global hand, foot, and mouth disease treatment market is segmented into drug type, route of administration, distribution channel, and company. Based on drug type, the market is divided into pain relievers, non-steroidal anti-inflammatory drugs, and nucleoside analogue antivirals. Based on route of administration, the market is divided into topical, oral, and intravenous. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising research and development activities in the country.
Market Players
Johnson & Johnson, GlaxoSmithKline plc., Emergex Vaccines Holdings Ltd, Takeda Pharmaceutical Co Ltd, CJ HealthCare Corp., and Adimmune Corp are some of the leading companies operating in the market.


Report Scope:
In this report, global hand, foot, and mouth disease treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Hand, Foot, and Mouth Disease Treatment Market, By Drug Type:
oPain Relievers
oNon-Steroidal Anti-inflammatory Drugs
oNucleoside Analogue Antivirals
•Hand, Foot, and Mouth Disease Treatment Market, By Route of Administration:
oTopical
oOral
oIntravenous
•Hand, Foot, and Mouth Disease Treatment Market, By Distribution Channel:
oHospital Pharmacies
oRetail Pharmacies
oOnline Pharmacies
•Hand, Foot, and Mouth Disease Treatment Market, By Region:
oNorth America
United States
Canada
Mexico
oAsia-Pacific
China
India
Japan
Australia
South Korea
oEurope & CIS
Germany
France
United Kingdom
Spain
Italy
oSouth America
Brazil
Argentina
Colombia
oMiddle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape

Competitive Landscape Detailed analysis of the major companies present in Hand, Foot, and Mouth Disease Treatment Market

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).

Content
Table of Contents

1.Product Overview
2.Research Methodology
3.Impact of COVID-19 on Global Hand, Foot, and Mouth Disease Treatment Market
4.Voice of Customer
5.Executive Summary
6.Clinical Trial Analysis
7.Global Hand, Foot, and Mouth Disease Treatment Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals)
7.2.2.By Route of Administration (Topical, Oral, Intravenous)
7.2.3.By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
7.2.4.By Company (2021)
7.2.5.By Region
7.3.Market Map
8.North America Hand, Foot, and Mouth Disease Treatment Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Drug Type
8.2.2.By Route of Administration
8.2.3.By Distribution Channel
8.2.4.By Country
8.3.North America: Country Analysis
8.3.1.United States Hand, Foot, and Mouth Disease Treatment Market Outlook
8.3.1.1.Market Size & Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share & Forecast
8.3.1.2.1.By Drug Type
8.3.1.2.2.By Route of Administration
8.3.1.2.3.By Distribution Channel
8.3.2.Mexico Hand, Foot, and Mouth Disease Treatment Market Outlook
8.3.2.1.Market Size & Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share & Forecast
8.3.2.2.1.By Drug Type
8.3.2.2.2.By Route of Administration
8.3.2.2.3.By Distribution Channel
8.3.3.Canada Hand, Foot, and Mouth Disease Treatment Market Outlook
8.3.3.1.Market Size & Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share & Forecast
8.3.3.2.1.By Drug Type
8.3.3.2.2.By Route of Administration
8.3.3.2.3.By Distribution Channel
9.Europe Hand, Foot, and Mouth Disease Treatment Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Drug Type
9.2.2.By Route of Administration
9.2.3.By Distribution Channel
9.2.4.By Country
9.3.Europe: Country Analysis
9.3.1.France Hand, Foot, and Mouth Disease Treatment Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.By Drug Type
9.3.1.2.2.By Route of Administration
9.3.1.2.3.By Distribution Channel
9.3.2.Germany Hand, Foot, and Mouth Disease Treatment Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.By Drug Type
9.3.2.2.2.By Route of Administration
9.3.2.2.3.By Distribution Channel
9.3.3.United Kingdom Hand, Foot, and Mouth Disease Treatment Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.By Drug Type
9.3.3.2.2.By Route of Administration
9.3.3.2.3.By Distribution Channel
9.3.4.Italy Hand, Foot, and Mouth Disease Treatment Market Outlook
9.3.4.1.Market Size & Forecast
9.3.4.1.1.By Value
9.3.4.2.Market Share & Forecast
9.3.4.2.1.By Drug Type
9.3.4.2.2.By Route of Administration
9.3.4.2.3.By Distribution Channel
9.3.5.Spain Hand, Foot, and Mouth Disease Treatment Market Outlook
9.3.5.1.Market Size & Forecast
9.3.5.1.1.By Value
9.3.5.2.Market Share & Forecast
9.3.5.2.1.By Drug Type
9.3.5.2.2.By Route of Administration
9.3.5.2.3.By Distribution Channel
10.Asia-Pacific Hand, Foot, and Mouth Disease Treatment Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Drug Type
10.2.2.By Route of Administration
10.2.3.By Distribution Channel
10.2.4.By Country
10.3.Asia-Pacific: Country Analysis
10.3.1.China Hand, Foot, and Mouth Disease Treatment Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.By Drug Type
10.3.1.2.2.By Route of Administration
10.3.1.2.3.By Distribution Channel
10.3.2.India Hand, Foot, and Mouth Disease Treatment Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.By Drug Type
10.3.2.2.2.By Route of Administration
10.3.2.2.3.By Distribution Channel
10.3.3.Japan Hand, Foot, and Mouth Disease Treatment Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.By Drug Type
10.3.3.2.2.By Route of Administration
10.3.3.2.3.By Distribution Channel
10.3.4.South Korea Hand, Foot, and Mouth Disease Treatment Market Outlook
10.3.4.1.Market Size & Forecast
10.3.4.1.1.By Value
10.3.4.2.Market Share & Forecast
10.3.4.2.1.By Drug Type
10.3.4.2.2.By Route of Administration
10.3.4.2.3.By Distribution Channel
10.3.5.Australia Hand, Foot, and Mouth Disease Treatment Market Outlook
10.3.5.1.Market Size & Forecast
10.3.5.1.1.By Value
10.3.5.2.Market Share & Forecast
10.3.5.2.1.By Drug Type
10.3.5.2.2.By Route of Administration
10.3.5.2.3.By Distribution Channel
11.South America Hand, Foot, and Mouth Disease Treatment Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Drug Type
11.2.2.By Route of Administration
11.2.3.By Distribution Channel
11.2.4.By Country
11.3.South America: Country Analysis
11.3.1.Brazil Hand, Foot, and Mouth Disease Treatment Market Outlook
11.3.1.1.Market Size & Forecast
11.3.1.1.1.By Value
11.3.1.2.Market Share & Forecast
11.3.1.2.1.By Drug Type
11.3.1.2.2.By Route of Administration
11.3.1.2.3.By Distribution Channel
11.3.2.Argentina Hand, Foot, and Mouth Disease Treatment Market Outlook
11.3.2.1.Market Size & Forecast
11.3.2.1.1.By Value
11.3.2.2.Market Share & Forecast
11.3.2.2.1.By Drug Type
11.3.2.2.2.By Route of Administration
11.3.2.2.3.By Distribution Channel
11.3.3.Colombia Hand, Foot, and Mouth Disease Treatment Market Outlook
11.3.3.1.Market Size & Forecast
11.3.3.1.1.By Value
11.3.3.2.Market Share & Forecast
11.3.3.2.1.By Drug Type
11.3.3.2.2.By Route of Administration
11.3.3.2.3.By Distribution Channel
12.Middle East and Africa Hand, Foot, and Mouth Disease Treatment Market Outlook
12.1.Market Size & Forecast
12.1.1.By Value
12.2.Market Share & Forecast
12.2.1.By Drug Type
12.2.2.By Route of Administration
12.2.3.By Distribution Channel
12.2.4.By Country
12.3.MEA: Country Analysis
12.3.1.South Africa Hand, Foot, and Mouth Disease Treatment Market Outlook
12.3.1.1.Market Size & Forecast
12.3.1.1.1.By Value
12.3.1.2.Market Share & Forecast
12.3.1.2.1.By Drug Type
12.3.1.2.2.By Route of Administration
12.3.1.2.3.By Distribution Channel
12.3.2.Saudi Arabia Hand, Foot, and Mouth Disease Treatment Market Outlook
12.3.2.1.Market Size & Forecast
12.3.2.1.1.By Value
12.3.2.2.Market Share & Forecast
12.3.2.2.1.By Drug Type
12.3.2.2.2.By Route of Administration
12.3.2.2.3.By Distribution Channel
12.3.3.UAE Hand, Foot, and Mouth Disease Treatment Market Outlook
12.3.3.1.Market Size & Forecast
12.3.3.1.1.By Value
12.3.3.2.Market Share & Forecast
12.3.3.2.1.By Drug Type
12.3.3.2.2.By Route of Administration
12.3.3.2.3.By Distribution Channel
13.Market Dynamics
13.1.Drivers
13.2.Challenges
14.Market Trends & Developments
15.Competitive Landscape
15.1.Johnson & Johnson
15.2.GlaxoSmithKline plc.
15.3.Emergex Vaccines Holdings Ltd
15.4.Takeda Pharmaceutical Co Ltd
15.5.CJ HealthCare Corp.
15.6.Adimmune Corp
16.Strategic Recommendations